Dr. Evan Louis Silvi is a Brooklyn, New York based male Ophthalmologist who is specialized in Ophthalmology. Active license number of Dr. Evan Louis Silvi is 102292-1 for Ophthalmology in New York. Dr. Evan Louis Silvi is medically trained to diagnose, monitor and medically or surgically treat all ocular and visual disorders. This includes problems affecting the eye and its component structures, the eyelids, the orbit and the visual pathways. In so doing, patients can be prescribed vision services, including glasses and contact lenses.
Complete Profile:
Dr. Evan Louis Silvi speciality, credentials, practice address, contact phone number and fax are as below.
Patients can directly walk in or can call on the below given phone number for appointment.
Specialization:
Ophthalmology
Credentials:
M.D.
Gender:
Male
Practice Address:
7902 4th Ave, Brooklyn, New York, 11209-3907
Phone:
718-748-2550
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details are as mentioned below.
NPI Number:
1033102322
NPI Enumeration Date:
23 Aug, 2005
NPI Last Update On:
08 Jul, 2007
Medical Licenses:
Doctors can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Dr. Evan Louis Silvi are as mentioned below.
License Number
Specialization
State
Status
102292-1
Ophthalmology
New York
Primary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
281 Pondfield Rd, Bronxville, New York
Zip:
10708-4937
Phone Number:
914-961-7752
Fax Number:
--
Patients can reach Dr. Evan Louis Silvi at 7902 4th Ave, Brooklyn, New York or can call to book an appointment on 718-748-2550. Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 11 March, 2024.